MUMBAI, India, Sept. 7 -- Intellectual Property India has published a patent application (202617084745 A) filed by Mellicell, Inc. on July 10, 2026, for Methods And Compositions Of Polycyclic And A Dual Acting Nitroxide Compounds For Treatment Of Fat Cell Associated Diseases.
Inventors include Jagtap, Prakash; Pope, Benjamin D.; Basu, Madhumita; and Glieberman, Aaron L..
The application for the patent was published on September 04, 2026, under issue no. 36/2026.
Abstract: Described are compounds, compositions of polycyclic, water soluble and a dual acting nitroxide substituted compounds and methods useful as mitogen-activated protein (MAP) kinase-interacting kinases1 and 2 (MNK1 and MNK2) inhibitors, for the treatment of cancer, Alzheimer's disease, autism, fragile X syndrome, obesity and fat cell associated diseases such as liposarcoma, MASH, MAFLD, sarcopenic obesity and polycystic ovary syndrome, and a method for treating, preventing, or mitigating the effects of a migraine or symptoms related to a migraine and a nerve pain.
Disclaimer: Curated by HT Syndication.
